Handforth A, Sourkes T L
Eur J Pharmacol. 1975 Dec;34(2):311-9. doi: 10.1016/0014-2999(75)90257-5.
The increase in the dopamine (DA) concentration of rat (whole) brain induced by gamma-hydroxybutyrate was inhibited by the reputed dopamine agonists apomorphine, apocodeine, 2-bromo-alpha-ergocryptine, piribedil, ergocornine and 5,6-dihydroxy-2-dimethylaminotetralin. The last three drugs raised DA levels in saline controls. Haloperidol, which decreased DA in controls slightly, prevented any agonist-induced rise in controls. However, haloperidol antagonized only apomorphine and piribedil in regard to the inhibition of the gamma-hydroxybutyrate induced rise in DA; this neuroleptic did not affect the inhibition by the other agonists. It is concluded that these data provide evidence for local receptor control of DA synthesis and that the DA agonists do not act through a common mechanism.
γ-羟基丁酸诱导的大鼠(全)脑多巴胺(DA)浓度升高受到公认的多巴胺激动剂阿扑吗啡、阿朴可待因、2-溴-α-麦角隐亭、匹莫齐特、麦角角碱和5,6-二羟基-2-二甲基氨基四氢萘的抑制。后三种药物可提高生理盐水对照组中的DA水平。氟哌啶醇在对照组中可轻微降低DA水平,可防止任何激动剂诱导的对照组DA水平升高。然而,就抑制γ-羟基丁酸诱导的DA升高而言,氟哌啶醇仅拮抗阿扑吗啡和匹莫齐特;这种抗精神病药物不影响其他激动剂的抑制作用。结论是,这些数据为DA合成的局部受体控制提供了证据,并且DA激动剂并非通过共同机制起作用。